Description

According to our latest research, the global Human-mouse Chimeric Antibody market size will reach USD 29019 million in 2031, growing at a CAGR of 4.1% over the analysis period.

A human-mouse chimeric antibody is a type of monoclonal antibody engineered by combining the variable regions of a mouse antibody (which determines antigen specificity) with the constant regions of a human antibody. This design reduces immunogenicity in humans compared to fully murine antibodies, while retaining the mouse antibody’s ability to bind its target. Chimeric antibodies are typically around 65–70% human and are used in the treatment of cancers, autoimmune diseases, and transplant rejection.

This report is a detailed and comprehensive analysis for global Human-mouse Chimeric Antibody market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Human-mouse Chimeric Antibody market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human-mouse Chimeric Antibody market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human-mouse Chimeric Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human-mouse Chimeric Antibody market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human-mouse Chimeric Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human-mouse Chimeric Antibody market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche AG, Johnson & Johnson, Celltrion, Pfizer, Merck KGaA, Sanofi, Teva, Eli Lilly & Co, Amgen, Merck & Co, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Human-mouse Chimeric Antibody market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Infliximab
    Rituximab
    Emicizumab
    Cetuximab
    Esatuximab
    Other

Market segment by Application
    Cancers
    Autoimmune Diseases
    Transplant Rejection

Market segment by players, this report covers
    Roche AG
    Johnson & Johnson
    Celltrion
    Pfizer
    Merck KGaA
    Sanofi
    Teva
    Eli Lilly & Co
    Amgen
    Merck & Co
    Sandoz
    Shanghai Henlius Biopharmaceutical
    United Therapeutics
    Innovent Bio
    Mitsubishi Tanabe Pharma
    Kyowa Kirin

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human-mouse Chimeric Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human-mouse Chimeric Antibody, with revenue, gross margin, and global market share of Human-mouse Chimeric Antibody from 2020 to 2025.
Chapter 3, the Human-mouse Chimeric Antibody competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human-mouse Chimeric Antibody market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human-mouse Chimeric Antibody.
Chapter 13, to describe Human-mouse Chimeric Antibody research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Human-mouse Chimeric Antibody by Type
        1.3.1 Overview: Global Human-mouse Chimeric Antibody Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Human-mouse Chimeric Antibody Consumption Value Market Share by Type in 2024
        1.3.3 Infliximab
        1.3.4 Rituximab
        1.3.5 Emicizumab
        1.3.6 Cetuximab
        1.3.7 Esatuximab
        1.3.8 Other
    1.4 Global Human-mouse Chimeric Antibody Market by Application
        1.4.1 Overview: Global Human-mouse Chimeric Antibody Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Cancers
        1.4.3 Autoimmune Diseases
        1.4.4 Transplant Rejection
    1.5 Global Human-mouse Chimeric Antibody Market Size & Forecast
    1.6 Global Human-mouse Chimeric Antibody Market Size and Forecast by Region
        1.6.1 Global Human-mouse Chimeric Antibody Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Human-mouse Chimeric Antibody Market Size by Region, (2020-2031)
        1.6.3 North America Human-mouse Chimeric Antibody Market Size and Prospect (2020-2031)
        1.6.4 Europe Human-mouse Chimeric Antibody Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Human-mouse Chimeric Antibody Market Size and Prospect (2020-2031)
        1.6.6 South America Human-mouse Chimeric Antibody Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Human-mouse Chimeric Antibody Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Roche AG
        2.1.1 Roche AG Details
        2.1.2 Roche AG Major Business
        2.1.3 Roche AG Human-mouse Chimeric Antibody Product and Solutions
        2.1.4 Roche AG Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Roche AG Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Human-mouse Chimeric Antibody Product and Solutions
        2.2.4 Johnson & Johnson Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 Celltrion
        2.3.1 Celltrion Details
        2.3.2 Celltrion Major Business
        2.3.3 Celltrion Human-mouse Chimeric Antibody Product and Solutions
        2.3.4 Celltrion Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Celltrion Recent Developments and Future Plans
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Human-mouse Chimeric Antibody Product and Solutions
        2.4.4 Pfizer Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Pfizer Recent Developments and Future Plans
    2.5 Merck KGaA
        2.5.1 Merck KGaA Details
        2.5.2 Merck KGaA Major Business
        2.5.3 Merck KGaA Human-mouse Chimeric Antibody Product and Solutions
        2.5.4 Merck KGaA Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Merck KGaA Recent Developments and Future Plans
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi Human-mouse Chimeric Antibody Product and Solutions
        2.6.4 Sanofi Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Sanofi Recent Developments and Future Plans
    2.7 Teva
        2.7.1 Teva Details
        2.7.2 Teva Major Business
        2.7.3 Teva Human-mouse Chimeric Antibody Product and Solutions
        2.7.4 Teva Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Teva Recent Developments and Future Plans
    2.8 Eli Lilly & Co
        2.8.1 Eli Lilly & Co Details
        2.8.2 Eli Lilly & Co Major Business
        2.8.3 Eli Lilly & Co Human-mouse Chimeric Antibody Product and Solutions
        2.8.4 Eli Lilly & Co Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Eli Lilly & Co Recent Developments and Future Plans
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Human-mouse Chimeric Antibody Product and Solutions
        2.9.4 Amgen Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Amgen Recent Developments and Future Plans
    2.10 Merck & Co
        2.10.1 Merck & Co Details
        2.10.2 Merck & Co Major Business
        2.10.3 Merck & Co Human-mouse Chimeric Antibody Product and Solutions
        2.10.4 Merck & Co Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Merck & Co Recent Developments and Future Plans
    2.11 Sandoz
        2.11.1 Sandoz Details
        2.11.2 Sandoz Major Business
        2.11.3 Sandoz Human-mouse Chimeric Antibody Product and Solutions
        2.11.4 Sandoz Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Sandoz Recent Developments and Future Plans
    2.12 Shanghai Henlius Biopharmaceutical
        2.12.1 Shanghai Henlius Biopharmaceutical Details
        2.12.2 Shanghai Henlius Biopharmaceutical Major Business
        2.12.3 Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Product and Solutions
        2.12.4 Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Shanghai Henlius Biopharmaceutical Recent Developments and Future Plans
    2.13 United Therapeutics
        2.13.1 United Therapeutics Details
        2.13.2 United Therapeutics Major Business
        2.13.3 United Therapeutics Human-mouse Chimeric Antibody Product and Solutions
        2.13.4 United Therapeutics Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 United Therapeutics Recent Developments and Future Plans
    2.14 Innovent Bio
        2.14.1 Innovent Bio Details
        2.14.2 Innovent Bio Major Business
        2.14.3 Innovent Bio Human-mouse Chimeric Antibody Product and Solutions
        2.14.4 Innovent Bio Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Innovent Bio Recent Developments and Future Plans
    2.15 Mitsubishi Tanabe Pharma
        2.15.1 Mitsubishi Tanabe Pharma Details
        2.15.2 Mitsubishi Tanabe Pharma Major Business
        2.15.3 Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Product and Solutions
        2.15.4 Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
    2.16 Kyowa Kirin
        2.16.1 Kyowa Kirin Details
        2.16.2 Kyowa Kirin Major Business
        2.16.3 Kyowa Kirin Human-mouse Chimeric Antibody Product and Solutions
        2.16.4 Kyowa Kirin Human-mouse Chimeric Antibody Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Kyowa Kirin Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Human-mouse Chimeric Antibody Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Human-mouse Chimeric Antibody by Company Revenue
        3.2.2 Top 3 Human-mouse Chimeric Antibody Players Market Share in 2024
        3.2.3 Top 6 Human-mouse Chimeric Antibody Players Market Share in 2024
    3.3 Human-mouse Chimeric Antibody Market: Overall Company Footprint Analysis
        3.3.1 Human-mouse Chimeric Antibody Market: Region Footprint
        3.3.2 Human-mouse Chimeric Antibody Market: Company Product Type Footprint
        3.3.3 Human-mouse Chimeric Antibody Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Human-mouse Chimeric Antibody Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Human-mouse Chimeric Antibody Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2025)
    5.2 Global Human-mouse Chimeric Antibody Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Human-mouse Chimeric Antibody Consumption Value by Type (2020-2031)
    6.2 North America Human-mouse Chimeric Antibody Market Size by Application (2020-2031)
    6.3 North America Human-mouse Chimeric Antibody Market Size by Country
        6.3.1 North America Human-mouse Chimeric Antibody Consumption Value by Country (2020-2031)
        6.3.2 United States Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        6.3.3 Canada Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        6.3.4 Mexico Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Human-mouse Chimeric Antibody Consumption Value by Type (2020-2031)
    7.2 Europe Human-mouse Chimeric Antibody Consumption Value by Application (2020-2031)
    7.3 Europe Human-mouse Chimeric Antibody Market Size by Country
        7.3.1 Europe Human-mouse Chimeric Antibody Consumption Value by Country (2020-2031)
        7.3.2 Germany Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        7.3.3 France Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        7.3.5 Russia Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        7.3.6 Italy Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Human-mouse Chimeric Antibody Market Size by Region
        8.3.1 Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Region (2020-2031)
        8.3.2 China Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        8.3.3 Japan Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        8.3.4 South Korea Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        8.3.5 India Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        8.3.7 Australia Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Human-mouse Chimeric Antibody Consumption Value by Type (2020-2031)
    9.2 South America Human-mouse Chimeric Antibody Consumption Value by Application (2020-2031)
    9.3 South America Human-mouse Chimeric Antibody Market Size by Country
        9.3.1 South America Human-mouse Chimeric Antibody Consumption Value by Country (2020-2031)
        9.3.2 Brazil Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        9.3.3 Argentina Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Human-mouse Chimeric Antibody Market Size by Country
        10.3.1 Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Country (2020-2031)
        10.3.2 Turkey Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)
        10.3.4 UAE Human-mouse Chimeric Antibody Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Human-mouse Chimeric Antibody Market Drivers
    11.2 Human-mouse Chimeric Antibody Market Restraints
    11.3 Human-mouse Chimeric Antibody Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Human-mouse Chimeric Antibody Industry Chain
    12.2 Human-mouse Chimeric Antibody Upstream Analysis
    12.3 Human-mouse Chimeric Antibody Midstream Analysis
    12.4 Human-mouse Chimeric Antibody Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Human-mouse Chimeric Antibody Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Human-mouse Chimeric Antibody Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Human-mouse Chimeric Antibody Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Human-mouse Chimeric Antibody Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Roche AG Company Information, Head Office, and Major Competitors
 Table 6. Roche AG Major Business
 Table 7. Roche AG Human-mouse Chimeric Antibody Product and Solutions
 Table 8. Roche AG Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Roche AG Recent Developments and Future Plans
 Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
 Table 11. Johnson & Johnson Major Business
 Table 12. Johnson & Johnson Human-mouse Chimeric Antibody Product and Solutions
 Table 13. Johnson & Johnson Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Johnson & Johnson Recent Developments and Future Plans
 Table 15. Celltrion Company Information, Head Office, and Major Competitors
 Table 16. Celltrion Major Business
 Table 17. Celltrion Human-mouse Chimeric Antibody Product and Solutions
 Table 18. Celltrion Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Pfizer Company Information, Head Office, and Major Competitors
 Table 20. Pfizer Major Business
 Table 21. Pfizer Human-mouse Chimeric Antibody Product and Solutions
 Table 22. Pfizer Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Pfizer Recent Developments and Future Plans
 Table 24. Merck KGaA Company Information, Head Office, and Major Competitors
 Table 25. Merck KGaA Major Business
 Table 26. Merck KGaA Human-mouse Chimeric Antibody Product and Solutions
 Table 27. Merck KGaA Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Merck KGaA Recent Developments and Future Plans
 Table 29. Sanofi Company Information, Head Office, and Major Competitors
 Table 30. Sanofi Major Business
 Table 31. Sanofi Human-mouse Chimeric Antibody Product and Solutions
 Table 32. Sanofi Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Sanofi Recent Developments and Future Plans
 Table 34. Teva Company Information, Head Office, and Major Competitors
 Table 35. Teva Major Business
 Table 36. Teva Human-mouse Chimeric Antibody Product and Solutions
 Table 37. Teva Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Teva Recent Developments and Future Plans
 Table 39. Eli Lilly & Co Company Information, Head Office, and Major Competitors
 Table 40. Eli Lilly & Co Major Business
 Table 41. Eli Lilly & Co Human-mouse Chimeric Antibody Product and Solutions
 Table 42. Eli Lilly & Co Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Eli Lilly & Co Recent Developments and Future Plans
 Table 44. Amgen Company Information, Head Office, and Major Competitors
 Table 45. Amgen Major Business
 Table 46. Amgen Human-mouse Chimeric Antibody Product and Solutions
 Table 47. Amgen Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Amgen Recent Developments and Future Plans
 Table 49. Merck & Co Company Information, Head Office, and Major Competitors
 Table 50. Merck & Co Major Business
 Table 51. Merck & Co Human-mouse Chimeric Antibody Product and Solutions
 Table 52. Merck & Co Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Merck & Co Recent Developments and Future Plans
 Table 54. Sandoz Company Information, Head Office, and Major Competitors
 Table 55. Sandoz Major Business
 Table 56. Sandoz Human-mouse Chimeric Antibody Product and Solutions
 Table 57. Sandoz Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Sandoz Recent Developments and Future Plans
 Table 59. Shanghai Henlius Biopharmaceutical Company Information, Head Office, and Major Competitors
 Table 60. Shanghai Henlius Biopharmaceutical Major Business
 Table 61. Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Product and Solutions
 Table 62. Shanghai Henlius Biopharmaceutical Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Shanghai Henlius Biopharmaceutical Recent Developments and Future Plans
 Table 64. United Therapeutics Company Information, Head Office, and Major Competitors
 Table 65. United Therapeutics Major Business
 Table 66. United Therapeutics Human-mouse Chimeric Antibody Product and Solutions
 Table 67. United Therapeutics Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. United Therapeutics Recent Developments and Future Plans
 Table 69. Innovent Bio Company Information, Head Office, and Major Competitors
 Table 70. Innovent Bio Major Business
 Table 71. Innovent Bio Human-mouse Chimeric Antibody Product and Solutions
 Table 72. Innovent Bio Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Innovent Bio Recent Developments and Future Plans
 Table 74. Mitsubishi Tanabe Pharma Company Information, Head Office, and Major Competitors
 Table 75. Mitsubishi Tanabe Pharma Major Business
 Table 76. Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Product and Solutions
 Table 77. Mitsubishi Tanabe Pharma Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
 Table 79. Kyowa Kirin Company Information, Head Office, and Major Competitors
 Table 80. Kyowa Kirin Major Business
 Table 81. Kyowa Kirin Human-mouse Chimeric Antibody Product and Solutions
 Table 82. Kyowa Kirin Human-mouse Chimeric Antibody Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Kyowa Kirin Recent Developments and Future Plans
 Table 84. Global Human-mouse Chimeric Antibody Revenue (USD Million) by Players (2020-2025)
 Table 85. Global Human-mouse Chimeric Antibody Revenue Share by Players (2020-2025)
 Table 86. Breakdown of Human-mouse Chimeric Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 87. Market Position of Players in Human-mouse Chimeric Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 88. Head Office of Key Human-mouse Chimeric Antibody Players
 Table 89. Human-mouse Chimeric Antibody Market: Company Product Type Footprint
 Table 90. Human-mouse Chimeric Antibody Market: Company Product Application Footprint
 Table 91. Human-mouse Chimeric Antibody New Market Entrants and Barriers to Market Entry
 Table 92. Human-mouse Chimeric Antibody Mergers, Acquisition, Agreements, and Collaborations
 Table 93. Global Human-mouse Chimeric Antibody Consumption Value (USD Million) by Type (2020-2025)
 Table 94. Global Human-mouse Chimeric Antibody Consumption Value Share by Type (2020-2025)
 Table 95. Global Human-mouse Chimeric Antibody Consumption Value Forecast by Type (2026-2031)
 Table 96. Global Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025)
 Table 97. Global Human-mouse Chimeric Antibody Consumption Value Forecast by Application (2026-2031)
 Table 98. North America Human-mouse Chimeric Antibody Consumption Value by Type (2020-2025) & (USD Million)
 Table 99. North America Human-mouse Chimeric Antibody Consumption Value by Type (2026-2031) & (USD Million)
 Table 100. North America Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025) & (USD Million)
 Table 101. North America Human-mouse Chimeric Antibody Consumption Value by Application (2026-2031) & (USD Million)
 Table 102. North America Human-mouse Chimeric Antibody Consumption Value by Country (2020-2025) & (USD Million)
 Table 103. North America Human-mouse Chimeric Antibody Consumption Value by Country (2026-2031) & (USD Million)
 Table 104. Europe Human-mouse Chimeric Antibody Consumption Value by Type (2020-2025) & (USD Million)
 Table 105. Europe Human-mouse Chimeric Antibody Consumption Value by Type (2026-2031) & (USD Million)
 Table 106. Europe Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025) & (USD Million)
 Table 107. Europe Human-mouse Chimeric Antibody Consumption Value by Application (2026-2031) & (USD Million)
 Table 108. Europe Human-mouse Chimeric Antibody Consumption Value by Country (2020-2025) & (USD Million)
 Table 109. Europe Human-mouse Chimeric Antibody Consumption Value by Country (2026-2031) & (USD Million)
 Table 110. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Type (2020-2025) & (USD Million)
 Table 111. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Type (2026-2031) & (USD Million)
 Table 112. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025) & (USD Million)
 Table 113. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Application (2026-2031) & (USD Million)
 Table 114. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Region (2020-2025) & (USD Million)
 Table 115. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value by Region (2026-2031) & (USD Million)
 Table 116. South America Human-mouse Chimeric Antibody Consumption Value by Type (2020-2025) & (USD Million)
 Table 117. South America Human-mouse Chimeric Antibody Consumption Value by Type (2026-2031) & (USD Million)
 Table 118. South America Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025) & (USD Million)
 Table 119. South America Human-mouse Chimeric Antibody Consumption Value by Application (2026-2031) & (USD Million)
 Table 120. South America Human-mouse Chimeric Antibody Consumption Value by Country (2020-2025) & (USD Million)
 Table 121. South America Human-mouse Chimeric Antibody Consumption Value by Country (2026-2031) & (USD Million)
 Table 122. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Type (2020-2025) & (USD Million)
 Table 123. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Type (2026-2031) & (USD Million)
 Table 124. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Application (2020-2025) & (USD Million)
 Table 125. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Application (2026-2031) & (USD Million)
 Table 126. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Country (2020-2025) & (USD Million)
 Table 127. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value by Country (2026-2031) & (USD Million)
 Table 128. Global Key Players of Human-mouse Chimeric Antibody Upstream (Raw Materials)
 Table 129. Global Human-mouse Chimeric Antibody Typical Customers


List of Figures
 Figure 1. Human-mouse Chimeric Antibody Picture
 Figure 2. Global Human-mouse Chimeric Antibody Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Human-mouse Chimeric Antibody Consumption Value Market Share by Type in 2024
 Figure 4. Infliximab
 Figure 5. Rituximab
 Figure 6. Emicizumab
 Figure 7. Cetuximab
 Figure 8. Esatuximab
 Figure 9. Other
 Figure 10. Global Human-mouse Chimeric Antibody Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 11. Human-mouse Chimeric Antibody Consumption Value Market Share by Application in 2024
 Figure 12. Cancers Picture
 Figure 13. Autoimmune Diseases Picture
 Figure 14. Transplant Rejection Picture
 Figure 15. Global Human-mouse Chimeric Antibody Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 16. Global Human-mouse Chimeric Antibody Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 17. Global Market Human-mouse Chimeric Antibody Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 18. Global Human-mouse Chimeric Antibody Consumption Value Market Share by Region (2020-2031)
 Figure 19. Global Human-mouse Chimeric Antibody Consumption Value Market Share by Region in 2024
 Figure 20. North America Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 21. Europe Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 22. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 23. South America Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 24. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 25. Company Three Recent Developments and Future Plans
 Figure 26. Global Human-mouse Chimeric Antibody Revenue Share by Players in 2024
 Figure 27. Human-mouse Chimeric Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 28. Market Share of Human-mouse Chimeric Antibody by Player Revenue in 2024
 Figure 29. Top 3 Human-mouse Chimeric Antibody Players Market Share in 2024
 Figure 30. Top 6 Human-mouse Chimeric Antibody Players Market Share in 2024
 Figure 31. Global Human-mouse Chimeric Antibody Consumption Value Share by Type (2020-2025)
 Figure 32. Global Human-mouse Chimeric Antibody Market Share Forecast by Type (2026-2031)
 Figure 33. Global Human-mouse Chimeric Antibody Consumption Value Share by Application (2020-2025)
 Figure 34. Global Human-mouse Chimeric Antibody Market Share Forecast by Application (2026-2031)
 Figure 35. North America Human-mouse Chimeric Antibody Consumption Value Market Share by Type (2020-2031)
 Figure 36. North America Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2031)
 Figure 37. North America Human-mouse Chimeric Antibody Consumption Value Market Share by Country (2020-2031)
 Figure 38. United States Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 39. Canada Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 40. Mexico Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 41. Europe Human-mouse Chimeric Antibody Consumption Value Market Share by Type (2020-2031)
 Figure 42. Europe Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2031)
 Figure 43. Europe Human-mouse Chimeric Antibody Consumption Value Market Share by Country (2020-2031)
 Figure 44. Germany Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 45. France Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 46. United Kingdom Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 47. Russia Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 48. Italy Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 49. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value Market Share by Type (2020-2031)
 Figure 50. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2031)
 Figure 51. Asia-Pacific Human-mouse Chimeric Antibody Consumption Value Market Share by Region (2020-2031)
 Figure 52. China Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 53. Japan Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 54. South Korea Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 55. India Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 56. Southeast Asia Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 57. Australia Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 58. South America Human-mouse Chimeric Antibody Consumption Value Market Share by Type (2020-2031)
 Figure 59. South America Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2031)
 Figure 60. South America Human-mouse Chimeric Antibody Consumption Value Market Share by Country (2020-2031)
 Figure 61. Brazil Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 62. Argentina Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 63. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value Market Share by Type (2020-2031)
 Figure 64. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value Market Share by Application (2020-2031)
 Figure 65. Middle East & Africa Human-mouse Chimeric Antibody Consumption Value Market Share by Country (2020-2031)
 Figure 66. Turkey Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 67. Saudi Arabia Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 68. UAE Human-mouse Chimeric Antibody Consumption Value (2020-2031) & (USD Million)
 Figure 69. Human-mouse Chimeric Antibody Market Drivers
 Figure 70. Human-mouse Chimeric Antibody Market Restraints
 Figure 71. Human-mouse Chimeric Antibody Market Trends
 Figure 72. Porters Five Forces Analysis
 Figure 73. Human-mouse Chimeric Antibody Industrial Chain
 Figure 74. Methodology
 Figure 75. Research Process and Data Source

Companies Mentioned

Roche AG
Johnson & Johnson
Celltrion
Pfizer
Merck KGaA
Sanofi
Teva
Eli Lilly & Co
Amgen
Merck & Co
Sandoz
Shanghai Henlius Biopharmaceutical
United Therapeutics
Innovent Bio
Mitsubishi Tanabe Pharma
Kyowa Kirin